Home › Trials › NCT03552003

Prognostic index development for elderly patients with Hodgkin Lymphoma

Prospective Study on Elderly (≥ 65 Years) Patients Affected With Classical Hodgkin Lymphoma Undergoing Comprehensive Geriatric Assessment at Diagnosis

Observational Fondazione Italiana Linfomi - ETS · NCT03552003

This study is trying to create a tool to help doctors understand the health and treatment options for older patients, 65 and up, who have just been diagnosed with Hodgkin Lymphoma.

Quick facts

Study typeObservational
Enrollment400 (estimated)
Ages65 Years and up
SexAll
SponsorFondazione Italiana Linfomi - ETS Academic / other
Locations44 sites (Alessandria and 43 other locations)
Trial IDNCT03552003 on ClinicalTrials.gov

What this trial studies

This study aims to create a prognostic index specifically for elderly patients aged 65 and older who have been newly diagnosed with classical Hodgkin Lymphoma. It involves a prospective observational approach where consecutive cases are registered following a Comprehensive Geriatric Assessment (CGA) before any treatment is administered. The study collects data on patients' activities of daily living, instrumental activities of daily living, and geriatric assessment scores to evaluate their health status and treatment eligibility. Patients who are deemed ineligible for treatment or only suitable for palliative care after the CGA will also be included in the study.

Who should consider this trial

Good fit: Ideal candidates for this study are elderly patients aged 65 and older who have been newly diagnosed with classical Hodgkin Lymphoma.

Not a fit: Patients who are younger than 65 years or those with a prior history of treatment for Hodgkin Lymphoma will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could provide a tailored prognostic tool to improve treatment decisions and outcomes for elderly patients with Hodgkin Lymphoma.

How similar studies have performed: While there have been studies focusing on Hodgkin Lymphoma, this specific approach targeting the elderly population with a comprehensive geriatric assessment is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. Diagnosis of classical Hodgkin Lymphoma
2. Age ≥ 65 year
3. Evaluation of Comprehensive Geriatric Assessment at baseline
4. Signed informed consent
5. Previously untreated patients

Exclusion Criteria:

None

Where this trial is running

Alessandria and 43 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions Classical Hodgkin LymphomaHodgkinElderly patientsCGA
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.